AMG
52
2
COF
50
3
PFG
33
-3
CMCSA
39
-2
DTE
54
-2
CFG
64
6
VLO
50
-2
GILD
46
-10
AMAT
58
-3
WFC
69
6
JPM
69
13
NWSA
73
3
INTU
67
-2
UAL
31
2
ROP
42
-3
PCAR
27
-7
JNJ
51
10
SYK
37
-2
EXPE
56
2
CI
50
4
AMG
52
2
COF
50
3
PFG
33
-3
CMCSA
39
-2
DTE
54
-2
CFG
64
6
VLO
50
-2
GILD
46
-10
AMAT
58
-3
WFC
69
6
JPM
69
13
NWSA
73
3
INTU
67
-2
UAL
31
2
ROP
42
-3
PCAR
27
-7
JNJ
51
10
SYK
37
-2
EXPE
56
2
CI
50
4
Financhill
Back

Builders FirstSource Vs. Akero Therapeutics Industry Stock Comparison

Sell
29

BLDR
Builders FirstSource

Last Price:
$106.84
Seasonality Move:
4.9%
Buy
60

AKRO
Akero Therapeutics

Last Price:
$54.99
Seasonality Move:
30.3%
Sell
29
Builders FirstSource (BLDR) is a Sell

Is Builders FirstSource a Buy, Sell or Hold?

  • The current Builders FirstSource [BLDR] share price is $106.85. The Score for BLDR is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • BLDR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $54.90. The Score for AKRO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BLDR Stock Price Chart

What is Builders FirstSource's stock price today?

  • The Builders FirstSource share price today is $106.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLDR is experiencing selling pressure, which indicates risk of future bearish movement.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $54.90
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.

BLDR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.31 Sell
Relative Strength Index (14 RSI): 41.32 Sell
Chaikin Money Flow: -1964190 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (108.05 - 116.23) Sell
Bollinger Bands (100): (109.85 - 146.43) Sell

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.1 Buy
Relative Strength Index (14 RSI): 65.99 Buy
Chaikin Money Flow: 553934 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.79 - 55.09) Buy
Bollinger Bands (100): (39.04 - 52.12) Buy

BLDR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.19 Sell
20-day SMA: 110.66 Sell
50-day SMA: 114.33 Sell
200-day SMA: 151.45 Sell
8-day EMA: 110.61 Sell
20-day EMA: 111.81 Sell
50-day EMA: 116.3 Sell
200-day EMA: 139.5 Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.68 Buy
20-day SMA: 51.68 Buy
50-day SMA: 44.82 Buy
200-day SMA: 37.22 Buy
8-day EMA: 54.44 Buy
20-day EMA: 51.63 Buy
50-day EMA: 47.35 Buy
200-day EMA: 39.05 Buy

Builders FirstSource Earnings Growth & BLDR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.46 per share, an increase next quarter of $0.27 per share, a decrease this year of $3.10 per share, and an increase next year of $1.48 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

Builders FirstSource Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):